arsenic trioxide has been researched along with oligonucleotides in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, D; Fei, J; Gu, J; Huang, K; Li, Y; Lin, C; Yao, J; Zhu, X | 1 |
| Castanotto, D; Liu, X; Shemi, A; Stein, CA; Zhang, X | 1 |
2 other study(ies) available for arsenic trioxide and oligonucleotides
| Article | Year |
|---|---|
Anti-miR-21 oligonucleotide sensitizes leukemic K562 cells to arsenic trioxide by inducing apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Arsenic Trioxide; Arsenicals; Cell Cycle; G1 Phase; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; MicroRNAs; Oligonucleotides; Oxides; RNA-Binding Proteins; Up-Regulation | 2010 |
Ammonium and arsenic trioxide are potent facilitators of oligonucleotide function when delivered by gymnosis.
Topics: Ammonium Compounds; Apoptosis; Arsenic Trioxide; Cell Nucleus; Cell Proliferation; Humans; Jurkat Cells; Oligonucleotides | 2018 |